Krishna Institu.
Krishna Institute of Medical Sciences Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
KIMS Hospitals expects year-on-year growth in top line and bottom line, aiming to maintain historical growth rates seen over the last 10-15 years. KIMS Hospitals expects year-on-year growth in both topline and bottomline, aiming to maintain the historical growth trajectory of the past 10-15 years.
From Krishna Institu.'s Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- KIMS Hospitals expects year-on-year growth in top line and bottom line, aiming to maintain historical growth rates seen over the last 10-15 years. (Page 23)
- Core markets like Telangana, Andhra Pradesh, Maharashtra, Karnataka, and Kerala will be the focus for growth, mainly via greenfield projects and acquisitions. (Pages 19, 23)
- New hospitals like Kondapur and Rajahmundry are expected to scale up, with Kondapur showing a 40% revenue growth shortly after commissioning. (Pages 17, 18)
- Andhra Pradesh cluster shows strong, continuous growth with addition of specialties like cancer care aiding ARPOB increase. (Page 17)
- Utilization in mature clusters is at around 61%-65%, expected to improve to 65%-70% by FY 2030 without adding bed capacity. (Page 15)
2 more points from Krishna Institu.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Krishna Institu. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current FY '27 CAPEX is around INR 100-125 crore over the next nine months, mostly tied to Rajahmundry hospital (INR 60-75 crore) and minor additional spend in Kondapur and Secunderabad.
- Maintenance CAPEX is estimated at around INR 100 crore per year for the next 3-4 years.
- Majority of new CAPEX has been completed; future spends will be more focused on consolidating existing assets.
- New greenfield hospital opportunities (~300-350 beds, scalable by 100 beds) are primarily planned for FY '28 onwards in core markets (Maharashtra, Kerala, Telangana, Andhra Pradesh); Karnataka will continue via greenfield route.
2 more points from Krishna Institu.'s call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Krishna Institu. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Krishna Institu. said on order book & pipeline — free account, 30 seconds.
Krishna Institu. — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Krishna Institute of Medical Sciences Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Health (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Krishna Institu. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Krishna Institu. Q1 FY27 results?
KIMS Hospitals expects year-on-year growth in top line and bottom line, aiming to maintain historical growth rates seen over the last 10-15 years. KIMS Hospitals expects year-on-year growth in both topline and bottomline, aiming to maintain the historical growth trajectory of the past 10-15 years.
What is Krishna Institu. share price analysis?
Krishna Institu. currently shows a below-average growth signal. The stock trades at a P/E of 138.1 with a market cap of ₹28,796 Cr. Investors should review the full earnings analysis for detailed insights.
Is Krishna Institu. planning capital expenditure?
Current FY '27 CAPEX is around INR 100-125 crore over the next nine months, mostly tied to Rajahmundry hospital (INR 60-75 crore) and minor additional spend in Kondapur and Secunderabad.
Keep Krishna Institu. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.